Trial Profile
Safety of Vascugel Treatment After Creation of Arteriovenous Access for Haemodialysis Use
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs SRM 003 (Primary)
- Indications Arteriovenous fistula
- Focus Adverse reactions
- Sponsors Pervasis Therapeutics
- 18 Sep 2014 New trial record